| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 157, Issue 2 689-699, Copyright © 1996 by American Association of Immunologists
ARTICLES |
E Williamson, P Garside, JA Bradley and AM Mowat
Department of Immunology, Western Infirmary, University of Glasgow, Scotland.
Distinct forms of graft-vs-host disease (GVHD) occur in (C57B1/6 x DBA/2)F1 (BDF1) mice inoculated with either C57B1/6 or DBA/2 parental spleen cells, and it has been suggested that this reflects differential activation of CD4+ Th cell subsets. Transfer of B6 cells produces an acute GVHD, during which an early period of lymphoid hyperplasia precedes immunosuppression, weight loss, and mortality, and a Th1 pattern of cytokines is produced. Conversely, transfer of DBA/2 cells induces a chronic GVHD, in which no weight loss or mortality is observed, but an autoimmune, SLE-like GVHD develops in association with a Th2 pattern of cytokines. Recent work indicates that IL-12 plays a central role in the polarization of Th cell-dependent responses, and here we have examined its role in polarizing GVHD, by administering or depleting IL-12 during the afferent phase of both the acute and chronic forms of GVHD in BDF1 mice. In vivo neutralization of endogenous IL-12 ameliorated acute GVHD, in association with reduced splenic NK cell activity, IFN-gamma production, immunosuppression, weight loss, and mortality. Conversely, administration of exogenous murine rIL-12 exacerbates this disease and converts the chronic GVHD into a lethal acute GVHD-like syndrome. These results indicate that IL-12 plays an important role in the development of acute, but not chronic, GVHD and suggest that differential production of IL-12 early in the disease may underlie these distinct outcomes of the GVHD in BDF1 mice injected with different parental cells.
This article has been cited by other articles:
|
|
 |
|
  M. Mohty, D. Blaise, C. Faucher, N. Vey, R. Bouabdallah, A.-M. Stoppa, F. Viret, G. Gravis, D. Olive, and B. Gaugler Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation Blood, December 15, 2005; 106(13): 4407 - 4411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Rao, M. P. Quinones, E. Garavito, Y. Kalkonde, F. Jimenez, C. Gibbons, J. Perez, P. Melby, W. Kuziel, R. L. Reddick, et al. CC Chemokine Receptor 2 Expression in Donor Cells Serves an Essential Role in Graft-versus-Host-Disease J. Immunol., November 1, 2003; 171(9): 4875 - 4885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kim, M.-T. Ochoa, S. R. Krutzik, O. Takeuchi, S. Uematsu, A. J. Legaspi, H. D. Brightbill, D. Holland, W. J. Cunliffe, S. Akira, et al. Activation of Toll-Like Receptor 2 in Acne Triggers Inflammatory Cytokine Responses J. Immunol., August 1, 2002; 169(3): 1535 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Arnold, C. Wasem, P. Juillard, P. Graber, I. Cima, C. Frutschi, S. Herren, S. Jakob, S. Alouani, C. Mueller, et al. IL-18-independent cytotoxic T lymphocyte activation and IFN-{gamma} production during experimental acute graft-versus-host disease Int. Immunol., May 1, 2002; 14(5): 503 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu, B. E. Anderson, M. E. Robert, J. M. McNiff, S. G. Emerson, W. D. Shlomchik, and M. J. Shlomchik Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease Blood, December 1, 2001; 98(12): 3367 - 3375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Reddy, T. Teshima, M. Kukuruga, R. Ordemann, C. Liu, K. Lowler, and J. L.M. Ferrara Interleukin-18 Regulates Acute Graft-Versus-Host Disease by Enhancing Fas-mediated Donor T Cell Apoptosis J. Exp. Med., November 12, 2001; 194(10): 1433 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Snider and H. Liang Early Intestinal Th1 Inflammation and Mucosal T Cell Recruitment During Acute Graft-Versus-Host Reaction J. Immunol., May 15, 2001; 166(10): 5991 - 5999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Li, L. Lu, Z. Wang, L. Wang, J. J. Fung, A. W. Thomson, and S. Qian IL-12 Antagonism Enhances Apoptotic Death of T Cells Within Hepatic Allografts from Flt3 Ligand-Treated Donors and Promotes Graft Acceptance J. Immunol., May 1, 2001; 166(9): 5619 - 5628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Lu, S. Sakamaki, H. Kuroda, T. Kusakabe, Y. Konuma, T. Akiyama, A. Fujimi, N. Takemoto, K. Nishiie, T. Matsunaga, et al. Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603 Blood, February 15, 2001; 97(4): 1123 - 1130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Blazar, C. J. Lees, P. J. Martin, R. J. Noelle, B. Kwon, W. Murphy, and P. A. Taylor Host T Cells Resist Graft-Versus-Host Disease Mediated by Donor Leukocyte Infusions J. Immunol., November 1, 2000; 165(9): 4901 - 4909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Okamoto, K. Kohno, T. Tanimoto, K. Iwaki, T. Ishihara, S. Akamatsu, H. Ikegami, and M. Kurimoto IL-18 Prevents the Development of Chronic Graft-Versus-Host Disease in Mice J. Immunol., June 1, 2000; 164(11): 6067 - 6074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Stuber, A Buschenfeld, A von Freier, T Arendt, and U R Folsch Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor alpha and not by the FasL-Fas interaction: effect of pentoxifylline on the development of mucosal atrophy Gut, August 1, 1999; 45(2): 229 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Flanagan, C. D. Jennings, and J. S. Bryson Th1 Cytokines and NK Cells Participate in the Development of Murine Syngeneic Graft-Versus-Host Disease J. Immunol., August 1, 1999; 163(3): 1170 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Buhlmann, M. Gonzalez, B. Ginther, A. Panoskaltsis-Mortari, B. R. Blazar, D. L. Greiner, A. A. Rossini, R. Flavell, and R. J. Noelle Cutting Edge: Sustained Expansion of CD8+ T Cells Requires CD154 Expression by Th Cells in Acute Graft Versus Host Disease J. Immunol., April 15, 1999; 162(8): 4373 - 4376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Okubo, E. Hagiwara, S. Ohno, T. Tsuji, A. Ihata, A. Ueda, A. Shirai, I. Aoki, K. Okuda, J.-i. Miyazaki, et al. Administration of an IL-12-Encoding DNA Plasmid Prevents the Development of Chronic Graft-Versus-Host Disease (GVHD) J. Immunol., April 1, 1999; 162(7): 4013 - 4017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Car, V. M. Eng, J. M. Lipman, and T. D. Anderson The Toxicology of Interleukin-12: A Review Toxicol Pathol, January 1, 1999; 27(1): 58 - 63. [Abstract] [PDF]
|
|
|
|
|
|
A. Shustov, P. Nguyen, F. Finkelman, K. B. Elkon, and C. S. Via Differential Expression of Fas and Fas Ligand in Acute and Chronic Graft-Versus-Host Disease: Up-Regulation of Fas and Fas Ligand Requires CD8+ T Cell Activation and IFN-{gamma} Production J. Immunol., September 15, 1998; 161(6): 2848 - 2855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Bagenstose, P. Salgame, and M. Monestier IL-12 Down-Regulates Autoantibody Production in Mercury-Induced Autoimmunity J. Immunol., February 15, 1998; 160(4): 1612 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sacco, H. Heremans, B. Echtenacher, W. A. Buurman, Z. Amraoui, M. Goldman, and P. Ghezzi Protective Effect of a Single Interleukin-12 (IL-12) Predose Against the Toxicity of Subsequent Chronic IL-12 in Mice: Role of Cytokines and Glucocorticoids Blood, December 1, 1997; 90(11): 4473 - 4479. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
